6-Methyl-2-(naphthalen-2-yl)-4,5-dihydropyridazin-3(2H)-one

Catalog No.: 
ACBIHV222
CAS No.: 
1956307-88-2
Molecular Formula: 
C15H14N2O
Molecular Weight: 
238.29
6-Methyl-2-(naphthalen-2-yl)-4,5-dihydropyridazin-3(2H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$879.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Methyl-2-(naphthalen-2-yl)-4,5-dihydropyridazin-3(2H)-one
IUPAC Name6-methyl-2-(naphthalen-2-yl)-4,5-dihydropyridazin-3(2H)-one
Molecular FormulaC15H14N2O
Molecular Weight238.29
SMILESO=C1CCC(C)=NN1C2=CC=C3C=CC=CC3=C2
InChI KeyQZMHRISRUBNHMA-UHFFFAOYSA-N
Synonym3(2H)-Pyridazinone, 4,5-dihydro-6-methyl-2-(2-naphthalenyl)-
CAS No.1956307-88-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBIHV222 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKYJE798 route compound structure diagram
    ACKYJE798580-13-2In Stock
  2. Plus
  3. ACKMCZ813 route compound structure diagram
    ACKMCZ8135157-08-4In Stock
  4. Then
  5. ACBIHV222 route product structure diagram
    ACBIHV2221956307-88-2
Inquiry

2. ACBIHV222 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKMCZ813 route compound structure diagram
    ACKMCZ8135157-08-4In Stock
  2. Plus
  3. ACCGDU246 route compound structure diagram
    ACCGDU246612-55-5In Stock
  4. Then
  5. ACBIHV222 route product structure diagram
    ACBIHV2221956307-88-2
Inquiry

3. ACBIHV222 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBIHV222 route product structure diagram
    ACBIHV2221956307-88-2
Inquiry

Comments (0)